RELOMBI Trademark

Trademark Overview

On Monday, June 22, 2009, a trademark application was filed for RELOMBI with the United States Patent and Trademark Office. The USPTO has given the RELOMBI trademark a serial number of 77765148. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 28, 2018. This trademark is owned by AstraZeneca AB. The RELOMBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders
relombi

General Information

Serial Number77765148
Word MarkRELOMBI
Filing DateMonday, June 22, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 28, 2018
Registration Number4100549
Registration DateTuesday, February 21, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 28, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSodertalje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSodertalje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSodertalje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, September 28, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, February 21, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 21, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, December 6, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 25, 20111(B) BASIS DELETED; NEW BASIS REQUESTED
Thursday, October 20, 2011NOTICE OF ALLOWANCE CANCELLED
Tuesday, October 25, 2011ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Friday, October 21, 201144(e) PETITION - GRANTED
Thursday, October 20, 2011ASSIGNED TO PETITION STAFF
Friday, October 7, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 7, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 19, 2011TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, June 7, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 6, 2011EXTENSION 3 GRANTED
Wednesday, June 1, 2011EXTENSION 3 FILED
Wednesday, June 1, 2011TEAS EXTENSION RECEIVED
Tuesday, May 31, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 31, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 28, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 27, 2010EXTENSION 2 GRANTED
Wednesday, December 1, 2010EXTENSION 2 FILED
Monday, December 27, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 1, 2010TEAS EXTENSION RECEIVED
Wednesday, July 21, 2010ASSIGNED TO EXAMINER
Tuesday, June 1, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 28, 2010EXTENSION 1 GRANTED
Friday, May 28, 2010EXTENSION 1 FILED
Friday, May 28, 2010TEAS EXTENSION RECEIVED
Tuesday, December 1, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2009PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2009NOTICE OF PUBLICATION
Thursday, August 6, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 6, 2009ASSIGNED TO LIE
Wednesday, July 29, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 28, 2009ASSIGNED TO EXAMINER
Thursday, June 25, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 25, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

relombi pharmaceutical treatment preparations disorders diseases diabetes cancer neurological infection psychiatric